6.4.5.1.3. salvage lymph node dissection. surgical management recurrent nodal metastases pelvis topic several retrospective analyses [991-993] sr . reported five-year bcr-free survival rates ranged 6% 31%. five-year os approximately 84% . biochemical recurrence rates found dependent psa salvage surgery location number positive nodes . addition rt lymphatic template salvage ln dissection may improve bcr rate . multi-centre retrospective study long-term outcomes 189 patients underwent salvage ln dissection reported worse previously described studies shorter follow-up . biochemical recurrence (bcr)-free survival ten years 11%. patients psa response salvage ln dissection patients receiving adt within six months salvage ln dissection lower risk death pca . majority patients (81%) received choline pet median psa salvage ln dissection 2.5 ng/ml. cohort study including patients treated salvage ln dissection via psma--radioguided surgery (psma-rgs), two-year bcr-free survival rate 32% . multi-variable analyses, higher pre-operative psa, higher number psma-avid lesions, multiple (pelvic plus retroperitoneal), retroperitoneal localisation lesions pre-operative imaging independent predictors bcr psma-rgs. high-level evidence oncological value salvage ln dissection (including adjuvant rt lns) still lacking .